NCI Signs Site License for BioDiscovery's Nexus Software | GenomeWeb
NEW YORK (GenomeWeb News) – BioDiscovery said last week that the National Cancer Institute has obtained a site license for its Nexus Copy Number software, which is used to analyze and visualize chromosomal aberrations from microarray data.
 
Nexus Copy Number can integrate data from thousands of arrays along with their clinical annotations in a single project, the company said.
 
Financial terms of the licensing agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.